Relationships among liver and kidney volumes, lean body mass and drug clearance

British Journal of Clinical Pharmacology

Volumn 46, Issue 5, 1998, Pages 447-452

  Nawaratne, Sumith ^a   Brien, Jo Anne E ^a   Seeman, Ego ^b   Fabiny, Robert ^b   Zalcberg, John ^b   Cosolo, Walter ^b   Angus, Peter ^b   Morgan, Denis J ^a  

^a MONASH UNIVERSITY   (Australia)

^b AUSTIN HEALTH   (Australia)

Author keywords

Antipyrine clearance; Creatinine clearance; Kidney volume; Lean body mass; Liver volume

Indexed keywords

ANTIPYRETIC ANALGESIC AGENT; CREATININE; PHENAZONE;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY SURFACE; BODY WEIGHT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG CLEARANCE; DRUG SALIVA LEVEL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; KIDNEY CLEARANCE; KIDNEY SIZE; LEAN BODY WEIGHT; LIVER CLEARANCE; LIVER WEIGHT; MALE; MULTIPLE REGRESSION; NOMOGRAM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING;

ADULT; AGED; ANTIPYRINE; BODY WEIGHT; CREATINE; FEMALE; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; LIVER; LIVER FUNCTION TESTS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED;

EID: 0031762988     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1998.00812.x     Document Type: Article

References (29)

1. Sheiner LB, Beal SL. Evaluation of methods for estimating population pharmacokinetic parameters II. Biexponential model and experimental pharmacokinetic data. J Pharmacokinet Biopharm 1981; 9: 635-651.
2. Holford NHG. A size standard for pharmacokinetics. Clin Pharmacokinet 1996; 30: 329-332.
3. Morgan DJ, Bray KM. Lean body mass as a predictor of drug dosage. Implications for drug therapy. Clin Pharmacokinet 1994; 26: 292-307.
4. Reilly JJ, Workman P. Normalisation of anti-cancer drug dosage using body weight and surface area: is it worthwhile? Cancer Chemother Pharmacol 1993; 32: 411-418.
5. Dawling S, Crome P. Clinical pharmacokinetic considerations in the elderly. Clin Pharmacokinet 1989; 17: 236-263.
6. Crome P, Flanagan RJ. Pharmacokinetic studies in elderly people are they necessary? Clin Pharmacokinet 1994; 26: 243-247.
7. Dawson WT. Relations between age and weight and dosage of drugs. Ann Intern Med 1940; 13: 1594-1613.
8. Mahmood I, Balian JD. Interspecies scaling: Predicting pharmacokinetic parameters of antiepileptic drugs in humans from animals with special emphasis on clearance. J Pharm Sci 1996; 4: 411-414.
9. Turner ST, Reilly SL. Fallacy of indexing renal and systemic hemodynamic measurements for body surface area. Am J Physiol 1995; 268: R978-R988.
10. Wade J, Kelman A, Kerr D, Robert J, Whiting B. Variability in the pharmacokinetics of epirubicin: a population analysis. Cancer Chemother Pharmacol 1992; 29: 391-395.
11. Hallynck T, Soep H, Thomis J, Boclaert J, Daneels R, Dettli L. Should clearance be normalised to body surface or to lean body mass? Br J Clin Pharmacol 1981; 11: 523-526.
12. Roubenoff R, Kehayias J. The meaning and measurement of lean body mass. Nutr Rev 1991; 49: 163-175.
13. Moore F. Energy and the maintenance of the body cell mass. J Parenter Enteral Nutr 1980; 4: 228-260.
14. Roberts C, Jackson L, Halliwell M, Branch R. The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man. Br J Clin Pharmacol 1976; 3: 907-913.
15. Pirttiaho H. Liver size in evaluating drug metabolising capacity in man. Int J Clin Pharmacol Biopharm 1979; 17: 271-276.
16. Swift CG, Homeida M, Halliwell M, Roberts CJ. Antipyrine disposition and liver size in the elderly. Eur J Clin Pharmacol 1978; 14: 149-152.
17. Bach B, Hanson JM, Kampmann JP, Rasmussen SN, Skovsted L. Disposition of antipyrine and phenytoin correlated with age and liver volume in man. Clin Pharmacokinet 1981; 6: 389-396.
18. 29 Levey AS, Perrone RD, Madias NE. Serum creatinine and renal function. Ann Rev Med 1988; 39: 465-490.
19. Jermain DM, Crismon ML, Martin ES. Population pharmacokinetics of lithium. Clin Pharm 1991; 10: 376-381.
20. Nawaratne S, Fabiny R, Brien JE, Zalcberg J, Cosolo W, Whan A, Morgan DJ. Accuracy of volume measurement using helical CT. J Comput Assist Tomogr 1997; 21: 481-486.
21. Formica C, Atkinson M, Nyulasi I, McKay J, Heale W, Seeman E. Body composition following hemodialysis: Studies using dual-energy X-ray absorptiometry and bioelectrical impedance analysis. Osteoporosis Int 1993; 3: 192-197.
22. Mazess R, Barden H, Bisek J, Hanson J. Dual-energy x-ray absorptiometry for total-body regional bone-mineral and soft-tissue composition. Am J Clin Nutr 1990; 51: 1106-1112.
23. Dubois D, Dubois E. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17: 863-871.
24. Shargel L, Cheung W, Yu ABC. High pressure liquid chromatographic analysis of antipyrine in small plasma samples. J Pharm Sci 1979; 68: 1052-1054.
25. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
26. Urata K, Kawasaki S, Matsunami H, et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatol 1995; 21: 1317-1321.
27. Fritschy P, Robotti G, Schneekloth G, Vock P. Measurement of liver volume by ultrasound and computed tomography. J Clin Ultrasound 1983; 11: 299-303.
28. Sharer JE, Wrighton SA. Identification of the human hepatic cytochromes P450 involved in the in vitro oxidation of antipyrine. Drug Metab Dispos 1996; 24: 487-494.
29. Hallynck T, Soep HH, Thomis J, Boelaert J, Daneels R. Prediction of creatinine clearance from serum creatinine concentration based on lean body mass. Clin Pharmacol Ther 1981; 30: 414-421.